12:00 AM
 | 
Sep 07, 2009
 |  BC Week In Review  |  Company News  |  Deals

Ceragenix deal

Ceragenix said an undisclosed company exercised an exclusive option to license rights to Ceragenix's CeraShield antimicrobial technology...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >